| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/26/2006 | EP1682073A2 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 07/26/2006 | EP0967991B1 Infectious bursitis vaccine |
| 07/26/2006 | CN1809584A Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
| 07/26/2006 | CN1809544A Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809536A Inhibitors of Akt activity |
| 07/26/2006 | CN1809381A HIV-1 envelope glycoproteins having unusual disulfide structure |
| 07/26/2006 | CN1809371A Lyase treatment for p. carinii |
| 07/26/2006 | CN1809364A Compositions and methods for increasing telomerase activity |
| 07/26/2006 | CN1809362A Substituted 1,4-diazepines and uses thereof |
| 07/26/2006 | CN1809354A Akt活性抑制剂 Akt activity inhibitor |
| 07/26/2006 | CN1809353A Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 07/26/2006 | CN1809352A Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 07/26/2006 | CN1809351A Inhibitors of Akt activity |
| 07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
| 07/26/2006 | CN1809340A Pharmaceutical products |
| 07/26/2006 | CN1265814C Tanacetum parthenium extract |
| 07/25/2006 | US7081461 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/25/2006 | CA2178107C Compositions for topical application to skin, hair or nails |
| 07/20/2006 | WO2005051297A3 Combination drug therapy to treat obesity |
| 07/20/2006 | WO2005046581A3 P18 in stem cell manipulations |
| 07/20/2006 | WO2005041886A3 Methods for generating or increasing revenues related to pain inhibitor commerce |
| 07/20/2006 | WO2005023195A3 Treatment of spinal cord injury |
| 07/20/2006 | WO2004110368A3 Combination therapy for the treatment of hypertension |
| 07/20/2006 | WO2004080413A3 Uses and formulations for transdermal or transmucosal application of active agents |
| 07/20/2006 | US20060161183 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use |
| 07/20/2006 | US20060161020 2-(Benzoylamino-3-phenylpropylamino]acetamide derivatives prevent the formation of insoluble A beta |
| 07/20/2006 | US20060160901 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160834 Combination therapy for the treatment of hypertension |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160776 Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160730 Administering pro-adrenomedullin N-terminal 20 peptide to induce neovascularization; use in treating coronary artery disease, peripheral vascular disease, and wounds; skin and organ (including heart) grafts |
| 07/20/2006 | US20060160087 Monitoring and treatment of amyotrophic lateral sclerosis |
| 07/20/2006 | US20060159745 Probiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159675 Compositions and methods for treating coagulation related disorders |
| 07/20/2006 | US20060159655 Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor |
| 07/20/2006 | US20060159622 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 07/20/2006 | US20060156487 Monoazo or ethenylene pyridine and aniline dye; intense and slightly selective colors with improved radiation resistance and colorfastness, for the oxidation dyeing of hair |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1680414A2 Substituted indazole-o-glucosides |
| 07/19/2006 | EP1680409A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 07/19/2006 | EP1680267A2 Method for producing abrasive non-woven cloth |
| 07/19/2006 | EP1680145A2 Methods and compositions for the treatment of neurological disease |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1680137A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 07/19/2006 | EP1680133A2 High affinity ligands for influenza virus and methods for their production |
| 07/19/2006 | EP1680132A2 Methods of using and compositions comprising thalidomide for treatment, modification and management of fibromyalgia |
| 07/19/2006 | EP1680130A2 Desensitization of complement activation using monocyte/macrophage inhibitory compounds |
| 07/19/2006 | EP1680124A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1680113A2 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications |
| 07/19/2006 | EP1680111A2 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 07/19/2006 | EP1680080A2 Neutrophil activation by immune response modifier compounds |
| 07/19/2006 | EP1680079A2 Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 07/19/2006 | EP1680073A2 Compounds and method for treating cancer |
| 07/19/2006 | EP1680067A2 Composition for the cosmetic treatment of age-related dermatological symptoms |
| 07/19/2006 | EP1679967A2 Methods of using and compositions comprising selective cytokine inhibitory drus for treatment, modification and management of pain |
| 07/19/2006 | EP1638492A4 Preoperative treatment of post operative pain |
| 07/19/2006 | EP1181298B1 Novel 8a- and 9a-15-membered lactams |
| 07/19/2006 | CN1806053A Method for identifying ligands specific for structural isoforms of proteins |
| 07/19/2006 | CN1805963A Cannabinoid receptor ligands and uses thereof |
| 07/19/2006 | CN1805784A Encapsulated essential oils |
| 07/19/2006 | CN1805760A Thorium-227 for use in radiotherapy of soft tissue disease |
| 07/19/2006 | CN1805755A Therapeutic use of anti- CS1 antibodies |
| 07/19/2006 | CN1805686A Mitotic kinesin inhibitors |
| 07/19/2006 | CN1805685A Treatment of demyelinating conditions |
| 07/19/2006 | CN1803839A Analogs of parathyroid hormone |
| 07/18/2006 | US7078538 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate |
| 07/18/2006 | US7078518 Forms of 5-Azacytidine |
| 07/18/2006 | US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | CA2207503C Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections |
| 07/13/2006 | WO2006073748A2 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | WO2006073729A1 Oral disintegrating dosage forms |
| 07/13/2006 | WO2006073359A1 Topical compositions comprising one or more of 44-thiouridine, isomaltitol and uridine |
| 07/13/2006 | WO2005046582A3 Polymeric interpenetrated network carrier and serial polymerization involving a crosslinked polymer network |
| 07/13/2006 | WO2005037213A3 Antiinflammatory inhibitors of respiratory burst in adherent neutrophils |
| 07/13/2006 | WO2005032454A3 Anti-muc-1 single chain antibodies for tumor targeting |
| 07/13/2006 | WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 07/13/2006 | US20060154991 administering 1-(5-methyl-2-propan-2-ylcyclohexyl)oxy-3-piperidin-1-ylpropan-2-ol, for the treatment fungal infection in humans and mammals; inhibitors of the budded-to-hyphal transition of yeasts |
| 07/13/2006 | US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/13/2006 | US20060154954 Combinations and use of selected pharmaceutically active compounds |
| 07/13/2006 | US20060154951 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| 07/13/2006 | US20060154917 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators |
| 07/13/2006 | US20060153829 Stable formulations of purified proteins |
| 07/13/2006 | CA2591138A1 Antibodies against antigen presenting cells and uses thereof |
| 07/12/2006 | EP1679059A2 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
| 07/12/2006 | EP1678328A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 07/12/2006 | EP1678298A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 07/12/2006 | EP1678199A2 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 07/12/2006 | EP1678168A2 P70s6 kinase modulators and method of use |
| 07/12/2006 | EP1678161A2 Thioether-substituted benzamides as inhibitors of factor xa |
| 07/12/2006 | EP1678096A2 Lpa receptor agonists and antagonists and methods of use |
| 07/12/2006 | EP1677824A2 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 07/12/2006 | EP1677812A2 Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
| 07/12/2006 | EP1677805A2 Pancreatic cancer treatment |
| 07/12/2006 | EP1677802A2 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |